MX361003B - Salinosporamidas y metodo para uso de las mismas. - Google Patents

Salinosporamidas y metodo para uso de las mismas.

Info

Publication number
MX361003B
MX361003B MX2013010748A MX2013010748A MX361003B MX 361003 B MX361003 B MX 361003B MX 2013010748 A MX2013010748 A MX 2013010748A MX 2013010748 A MX2013010748 A MX 2013010748A MX 361003 B MX361003 B MX 361003B
Authority
MX
Mexico
Prior art keywords
cnb476
cnb392
salinosporamides
strains
marine
Prior art date
Application number
MX2013010748A
Other languages
English (en)
Spanish (es)
Inventor
R Jensen Paul
J Mincer Tracy
H R Feling Robert
H Fenical William
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/600,854 external-priority patent/US7179834B2/en
Priority claimed from US10/838,157 external-priority patent/US7176232B2/en
Application filed by Univ California filed Critical Univ California
Publication of MX361003B publication Critical patent/MX361003B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MX2013010748A 2003-06-20 2004-06-18 Salinosporamidas y metodo para uso de las mismas. MX361003B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/600,854 US7179834B2 (en) 2002-06-24 2003-06-20 Salinosporamides and methods for use thereof
US10/838,157 US7176232B2 (en) 2002-06-24 2004-04-30 Salinosporamides and methods for use thereof
PCT/US2004/019453 WO2005003137A1 (en) 2003-06-20 2004-06-18 Salinosporamides and methods for use thereof

Publications (1)

Publication Number Publication Date
MX361003B true MX361003B (es) 2018-11-23

Family

ID=46713688

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013010748A MX361003B (es) 2003-06-20 2004-06-18 Salinosporamidas y metodo para uso de las mismas.

Country Status (8)

Country Link
KR (1) KR101315595B1 (ko)
CY (1) CY1116724T1 (ko)
DK (1) DK2441767T3 (ko)
ES (1) ES2546415T3 (ko)
IL (1) IL240236B (ko)
MX (1) MX361003B (ko)
PT (1) PT2441767E (ko)
SI (1) SI2441767T1 (ko)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1341414T3 (da) 2000-11-16 2013-03-25 Univ California Marint actinomycet-taxon til opdagelse af medikamenter og fermenteringsprodukter

Also Published As

Publication number Publication date
PT2441767E (pt) 2015-10-09
KR20120081637A (ko) 2012-07-19
SI2441767T1 (sl) 2015-10-30
ES2546415T3 (es) 2015-09-23
KR101315595B1 (ko) 2013-10-08
IL240236B (en) 2021-02-28
DK2441767T3 (en) 2015-08-24
CY1116724T1 (el) 2017-03-15
IL240236A0 (en) 2015-09-24

Similar Documents

Publication Publication Date Title
MXPA05013985A (es) Salinosporamidas y metodo para el uso de las mismas.
WO2006092213A8 (de) Pyrazolylcarboxanilide
NO20073123L (no) Mikroorganisme for dekontaminering av fumonisiner og anvendelse av denne, fremgangsmate for dekontaminering av fumonisiner og foradditiver inneholdende mikroorganismen.
MX349099B (es) Composición que comprende almidón como materia prima para la producción de etanol.
WO2007024756A3 (en) Reduced genome e. coli
RS20060250A (en) 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, method for the production thereof, and their use as antiphlogistics
WO2008064351A3 (en) (r)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs
WO2008073406A3 (en) Solvent tolerant microorganisms
MX2007010045A (es) Pirazolopirimidinas.
AU9157301A (en) Grain fractionation methods and products
AU2007249926A8 (en) Monocyclic heteroaryl compounds
WO2007018671A3 (en) Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
WO2003013435A3 (en) N-acetyl-d-glucosamine and process for producing n-acetyl-d-glucosamine
EA200700514A1 (ru) Способ получения гидрофобных полимеров
WO2007038586A3 (en) Methods to reduce organic impurity levels in polymers and products made therefrom
WO2011069105A3 (en) Process for producing fermentation products and fermentation medium compositions therefor
DE602005025390D1 (de) Bakterielles produkt marinen ursprungs, das sich zur verhinderung des durch makroalgen und wirbellose meerestiere verursachten makro- und mikro-biofouling eignet
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
WO2023192286A3 (en) Alkenyl succinimide compounds and their use
WO2007149560A3 (en) Fermentation and purification of actinomadura chromoprotein and related species
BR0316782A (pt) Produto de leite fermentado, processo para preparação de um produto de leite fermentado e uso da linhagem cnrz 244 de lactobacillus helveticus
MY149864A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
WO2008094617A3 (en) Crystalline forms of deferasirox
TW200716555A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
MX361003B (es) Salinosporamidas y metodo para uso de las mismas.